Oxford and AstraZeneca announce their vaccine is 70% effective on average in preliminary results By Martin Robinson, Chief Reporter For Mailonline Published: 07:14 GMT, 23 November 2020 | Updated: 07:14 GMT, 23 November 2020 The Oxford University/AstraZeneca coronavirus vaccine is 70 per cent effective at preventing COVID-19, preliminary results have revealed. The life-saving jab is Britain’s … Read more
Encouraging the public to visit bars and restaurants and then closing hospitality due to a spike in Covid-19 cases is not a ‘sensible way to run the epidemic’, a Government scientific adviser has said. Professor John Edmunds, a member of the Scientific Advisory Group for Emergencies (Sage), urged a long-term strategy when it comes to … Read more
No vaccine queue jump: Government vows ‘every single person in the UK’ will be offered a Covid-19 jab free on the NHS before private firms can sell them Healthcare providers will be able to source vaccines from jab manufacturers But such orders will be put at the ‘back of the queue’, government sources say Move … Read more
Pfizer‘s coronavirus vaccine could cost Britain £588million and wind up being seven times more expensive per dose than the one being developed by Oxford University. The jab, which the company this week claimed is 90 per cent effective and could be approved by regulators within weeks, is likely to cost at least £15 per dose … Read more
British drug giants Astrazeneca and Glaxosmithkline still in the race for a Covid jab By Matt Oliver For The Daily Mail Published: 21:53 GMT, 9 November 2020 | Updated: 22:20 GMT, 9 November 2020 Britain’s two biggest drugs companies are also developing Covid-19 vaccines. Potential jabs are being tested by FTSE 100 giants Astrazeneca and … Read more
Astrazeneca boss pins hopes on firm’s vaccine jab and antibody treatment to turn the tide in Covid fight By Matt Oliver For The Daily Mail Published: 21:52 GMT, 5 November 2020 | Updated: 21:52 GMT, 5 November 2020 British pharmaceuticals giant Astrazeneca warned that sales had been slowed by the coronavirus pandemic as it offered … Read more
AstraZeneca did not turn over coronavirus vaccine trial safety data to the US Food and Drug Administration (FDA) for one month, a new report claims. The late-stage study, being conducted with Oxford University, was put on hold on September 9 when a British participant was rushed to the hospital after suffering a serious reaction that … Read more
The world may be one step closer to getting a coronavirus jab after Oxford University’s vaccine candidate entered its final stage of tests in the US. UK drug giant AstraZeneca, which owns the rights to the vaccine, said it had enrolled 30,000 American volunteers to take part in its phase three clinical trial. It now means … Read more
Pharmaceutical giant AstraZeneca is now injecting volunteers with its new antibody treatment for Covid-19 in a bid to see if it will protect people and also help patients who are already ill. The British company, which is also manufacturing an experimental jab developed by experts at Oxford University, hope the monoclonal antibody therapy will prove … Read more
Pharmaceutical giant AstraZeneca has dismissed claims its experimental Covid-19 vaccine could be fast-tracked in the US amid reports Donald Trump wants to get it approved before the presidential election this autumn. White House insiders claim the US President is considering speeding up regulatory approval for the jab, originally developed by Oxford University scientists. Getting a … Read more